Compugen Ltd (CGEN)
Compugen Ltd (CGEN) is a biotechnology company based in Israel that focuses on the discovery and development of novel immuno-oncology and therapeutic antibody candidates. Leveraging its proprietary computational discovery platform, the company aims to identify innovative drug candidates across various therapeutic areas, primarily targeting cancer and other serious diseases.
Company News
Longboard (LBPH) gains 14% as the FDA grants the Breakthrough Therapy designation to its investigational epilepsy treatment candidate, bexicaserin, for patients aged two years or older.
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 200 points on Tuesday. The Dow traded up 0.53% to 37,505.25 while the NASDAQ rose 0.51% to 14,980.71. The S&P 500 also rose, gaining, 0.45% to 4,762.12. Check This Out: Cisco Systems, Electronic Arts And 2 Other Stocks Insiders Are Selling  Leading and...
Shares are halted for volatility but rise to highest levels since mid-2022 on resumed trading.
The company released its fourth-quarter and full-year results after the bell Monday.